首页 | 本学科首页   官方微博 | 高级检索  
     

宫颈癌68例MRI分期与临床及病理分期的对比
引用本文:孙长录,李慧,原聚祥,李振玉,彭保成,Chang-lu,JU-xiang,Zhen-yu,Bao-cheng. 宫颈癌68例MRI分期与临床及病理分期的对比[J]. 中原医刊, 2010, 0(6)
作者姓名:孙长录  李慧  原聚祥  李振玉  彭保成  Chang-lu  JU-xiang  Zhen-yu  Bao-cheng
摘    要:目的 分析宫颈癌MRI表现,评价MRI成像对宫颈癌术前分期的价值.方法 68例经病理证实的宫颈癌患者,在MRI上观察肿瘤的位置、大小、信号特征、浸润范围及累及宫旁的情况,进行MRI影像分期,其中56例MRI术前分期与手术、病理分期对照.结果 68例MRI分期分别Ⅰa 2例,Ⅰb 5例,Ⅱa 34例,Ⅱb 12例,Ⅲa 4例, Ⅲb 5例,Ⅳa 4例,Ⅳb 2例.MRI在判断宫颈癌发生部位的准确率为100%,判断宫旁浸润的准确率为86.7%,判断宫颈癌总的分期准确率为88%.结论 MRI能清楚显示宫颈癌病灶的侵犯范围,对宫颈癌的分期价值极高,对临床制定治疗方案及预后评估有重要意义,建议对宫颈癌患者进行常规检查.Abstract:Objective To analyze the MRI features of cervical carcinoma,and evaluate the value of MRI in staging of cervical carcinoma. Methods Pelvic MRI imaging was performed in 68 patients with cervical carcinoma proved by pathology.MRI images were analyzed for location,size,signal characteristics,extension of the primary tumor and surrounding tissue. MRI findings were compared with clinical staging and surgical pathologic findings.Results Based on MRI staging,stage Ⅰa was seen in 2 cases,Ⅰb in 5 cases,Ⅱa in 34 cases,Ⅱb in12 cases,Ⅲa in 4 cases,Ⅲb in 5 cases,Ⅳa in 4 cases,Ⅳb in 2 cases. The accuracy of MRI imaging in determination of tumor location was 100%, invasion the parauterine tissue was 86.7%. The total accuracy of MRI imaging staging was 88%.Conclusions MRI can well demonstrate the size and extension of the cervical carcinoma, MRI has important value in staging of cervical carcinoma,and very helpful in making the therapeutic plan.It is suggested that MRI should be regarded as a conventional study for the patients with cerivical carcinoma.

关 键 词:宫颈癌  MRI影像  临床  病理分期  cervical  carcinoma  study  准确率  术前分期  determination  of  clinical  staging  important  value  癌患者  conventional  治疗方案  预后评估  信号特征  浸润范围  分期价值  发生部位  常规检查

Comparative study of 68 MRI staging with clinical and pathologic staging of cervical carcinoma
Abstract:Cervical carcinoma MRI Neoplasm staging
Keywords:Cervical carcinoma MRI Neoplasm staging
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号